SCHEMBL2657366

SCHEMBL2657366

CC1CCC(N(CCc2cc(F)c(F)c(F)c2)C(=O)Nc2ncc(SC(C)(C)C(=O)O)s2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.38
PPARD Q03181 2/20 0.38
PPARA Q07869 2/20 0.38
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
CDK2 P24941 3/20 0.32
CCNE2 O96020 2/20 0.32
CCNE1 P24864 2/20 0.32
ITK Q08881 1/20 0.32
CDK9 P50750 2/20 0.32
CIT O14578 1/20 0.32
CASK O14936 1/20 0.32
AURKA O14965 1/20 0.32
GAK O14976 1/20 0.32
DCLK1 O15075 1/20 0.32
MAP3K7 O43318 1/20 0.32
CCNT1 O60563 1/20 0.32
ULK1 O75385 1/20 0.32
RPS6KA5 O75582 1/20 0.32
PAK3 O75914 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657364 1.00 PPARG (0.38) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2656683 0.92 PPARG (0.38) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2656686 0.92 PPARG (0.38) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2657881 0.92 PPARA (0.38) PPARGPPARDPPARAITK
SCHEMBL2657883 0.92 PPARA (0.38) PPARGPPARDPPARAITK
SCHEMBL2656405 0.89 PPARA (0.43) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2656403 0.89 PPARA (0.43) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2656147 0.89 PPARA (0.36) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2656145 0.89 PPARA (0.36) PPARGPPARDPPARAADORA2AADORA1
SCHEMBL2657828 0.88 PPARA (0.39) PPARGPPARDPPARACDK2ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041711-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2010-02-18 US claimed
EP-2099777-A1 UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2009-09-16 EP claimed
WO-2008084044-A1 UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2008-07-17 WO claimed
US-8362049-B2 Urea glucokinase activators NOVO NORDISK A/S (DK) 2013-01-29 US disclosed
US-8318778-B2 Urea glucokinase activators NOVO NORDISK A/S (DK) 2012-11-27 US disclosed
US-20120165375-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2012-06-28 US disclosed
US-20100041711-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2010-02-18 US disclosed
EP-2099777-A1 UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2009-09-16 EP disclosed
WO-2008084044-A1 UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041711-A1 Urea Glucokinase Activators GCK, GCKR, HK2 PPARG 623/4885PPARD 1230/4885PPARA 1441/4885
US-20120165375-A1 Urea Glucokinase Activators GCK, GCKR, HK2 PPARG 623/4885PPARD 1230/4885PPARA 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.